The Foundry :: Funding

Home / What We Do / Our Process / Funding

From the inception of the new company, The Foundry Team is focused on key value creation milestones. The technology is advanced using its seed funding until a larger infusion of capital is appropriate. At that point, The Foundry will look to its strong relationships with venture capital partners to provide the next round of funding for the new company. The Foundry funds their business through solid relationships with their extensive network of venture and private equity capital firms. Our experience can help secure seed capital and prepare for larger venture capital financing by building and presenting a cohesive funding strategy. We have partnered with the following groups for investment opportunities:

– ABS Ventures
– Advanced Technology Ventures
– BBT Fund LP
– Bluebird Development, LLC
– Cargill Ventures
– Cutlass Capital
– Delphi Ventures
– Domain Ventures
– Emergent Medical Ventures
– Frazier Healthcare Ventures
– H & Q Capital Management
– HLM Venture Partners
– Integral Capital Partners
– Latterell Venture Partners
– Morgan Stanley

– Morgenthaler Ventures
– New Enterprise Associates
– New Venture Partners
– Neuroventures
– OrbiMed Advisors
– Oxford Bioscience Partners
– Pinnacle Ventures
– Proquest
– Prospect Ventures
– Schroder Ventures Life Sciences
– Skyline Ventures
– Split Rock Partners, co-manager of St. Paul Venture Capital
– Three Arch Partners
– Venrock Associates